Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

637930

	registered interest
	date	16/11/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Strokes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the potential effect of the expiry of the National Stroke Strategy in 2017 on stroke patient outcomes.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	53167
	answer	answer is ministerial correction date of answer 23/11/2016 answer text <p>No formal assessment has been made of the potential effect of the expiry of the National Stroke Strategy in 2017 on stroke patient outcomes. However the quality of stroke care is continually monitored by the Sentinel Stroke National Audit Programme.</p><p> </p><p>The National Stroke Strategy remains valid and implementation of it continues. Action is being taken to ensure the progress made on stroke continues. This includes;</p><p> </p><p>- ongoing work in virtually all parts of the country to organise acute stroke care to ensure that all stroke patients, regardless of where they live or what time of the day or week they have their stroke, have access to high quality specialist care;</p><p> </p><p>- publication of the Cardiovascular Disease (CVD) Outcomes Strategy in 2013, which includes many stroke specific strategic ambitions;</p><p> </p><p>- a CVD collaborative group is being established to bring together relevant stakeholders in the field of CVD and provide a forum where relevant work being undertaken in this area and potential new initiatives can be discussed and responsibilities for action determined;</p><p> </p><p>- NHS England’s National Clinical Director for Stroke is working with Clinical Networks, Urgent and Emergency Care Networks, Clinical Commissioning Groups (CCGs) and Sustainability and Transformation Plan footprints on how stroke care is best delivered to local communities;</p><p> </p><p>- services for the management of transient ischaemic attack (TIA) are changing in many areas to meet the new standard that all TIA patients should be seen and assessed within 24 hours, not just high risk patients; and</p><p> </p><p>- CCGs are being encouraged to increase the geographical coverage of early supported discharge services.</p><p> </p><p>Prevention of stroke and CVDs is also a priority for NHS England, particularly attempting to reduce the very high prevalence of CVD in patients with mental health illness.</p> answering member constituency Warrington South answering member printed David Mowat grouped question UIN 53170 question first answered 23/11/2016 14:50:43 answering member 4080 label Biography information for David Mowat
	tabling member	4447 label Biography information for Maggie Throup

637931

	registered interest
	date	16/11/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Strokes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what objectives the National Stroke Strategy has remaining before its expiry in 2017.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	53170
	answer	answer is ministerial correction date of answer 23/11/2016 answer text <p>No formal assessment has been made of the potential effect of the expiry of the National Stroke Strategy in 2017 on stroke patient outcomes. However the quality of stroke care is continually monitored by the Sentinel Stroke National Audit Programme.</p><p> </p><p>The National Stroke Strategy remains valid and implementation of it continues. Action is being taken to ensure the progress made on stroke continues. This includes;</p><p> </p><p>- ongoing work in virtually all parts of the country to organise acute stroke care to ensure that all stroke patients, regardless of where they live or what time of the day or week they have their stroke, have access to high quality specialist care;</p><p> </p><p>- publication of the Cardiovascular Disease (CVD) Outcomes Strategy in 2013, which includes many stroke specific strategic ambitions;</p><p> </p><p>- a CVD collaborative group is being established to bring together relevant stakeholders in the field of CVD and provide a forum where relevant work being undertaken in this area and potential new initiatives can be discussed and responsibilities for action determined;</p><p> </p><p>- NHS England’s National Clinical Director for Stroke is working with Clinical Networks, Urgent and Emergency Care Networks, Clinical Commissioning Groups (CCGs) and Sustainability and Transformation Plan footprints on how stroke care is best delivered to local communities;</p><p> </p><p>- services for the management of transient ischaemic attack (TIA) are changing in many areas to meet the new standard that all TIA patients should be seen and assessed within 24 hours, not just high risk patients; and</p><p> </p><p>- CCGs are being encouraged to increase the geographical coverage of early supported discharge services.</p><p> </p><p>Prevention of stroke and CVDs is also a priority for NHS England, particularly attempting to reduce the very high prevalence of CVD in patients with mental health illness.</p> answering member constituency Warrington South answering member printed David Mowat grouped question UIN 53167 question first answered 23/11/2016 14:50:43 answering member 4080 label Biography information for David Mowat
	tabling member	4447 label Biography information for Maggie Throup

681209

	registered interest
	date	30/01/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what mechanisms NHS England has in place to ensure that clinical commissioning groups are fulfilling their statutory responsibility to commission certain health services to meet the reasonable requirements of the persons for whom it has responsibility in (a) the prescribing of medical nutrition according to NICE Clinical Guidance 32 2006 and (b) commissioning other health services in line with section 13(2) of the Health and Social Care Act 2012.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	62211
	answer	answer is ministerial correction date of answer 07/02/2017 answer text <p>NHS England has a statutory duty to carry out an annual performance assessment of each clinical commissioning group (CCG) and, in 2016/17, introduced the CCG Improvement and Assessment Framework. This framework is aligned to delivery of the Five Year Forward View and NHS Planning Guidance.</p><p> </p><p>The Framework brings together in one place NHS Constitution and other core performance and finance indicators, outcome goals and transformational challenges. CCGs are also assessed against a range of indicators that consider their delivery of commitments, improved health outcomes for their populations and whether they are well-led organisations. This provides assurance that CCGs are effective commissioning organisations.</p><p> </p><p>Where necessary, NHS England is supported by legislation in exercising formal powers of direction if it is satisfied that a CCG is failing or is at risk of failing to discharge its functions.</p><p> </p><p>It is a matter for CCGs to determine how best to commission services to meet the health needs of their local population, and they should have regard to National Institute for Health and Care Excellence guidance in doing so.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 07/02/2017 15:50:30 answering member 4080 label Biography information for David Mowat
	tabling member	4447 label Biography information for Maggie Throup

425115

	registered interest
	date	30/10/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Respiratory System: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will request that NICE publishes its reasons for including a recommendation on the use of C-reactive protein testing for patients presenting with lower respiratory tract infection in primary care in its guidance on pneumonia but not in its pneumonia draft quality statement.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	14209
	answer	answer is ministerial correction date of answer 09/11/2015 answer text <p>The prioritisation of topics for inclusion in quality standards is a matter for the National Institute for Health and Care Excellence (NICE). NICE has advised that its Quality Standards Advisory Committee considered the inclusion of a quality statement on the use of C-reactive protein testing for patients presenting with lower respiratory tract infection in primary care in its draft quality standard on pneumonia, but felt that this was not an area to be prioritised.</p><br /><p>The minutes of Quality Standards Advisory Committee meetings are published on NICE’s website at:</p><br /><p><a href="http://www.nice.org.uk/get-involved/meetings-in-public/quality-standards-advisory-committee" target="_blank">www.nice.org.uk/get-involved/meetings-in-public/quality-standards-advisory-committee</a></p><br /> <br /> <br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/11/2015 16:07:25 answering member 4020 label Biography information for George Freeman
	tabling member	4447 label Biography information for Maggie Throup

425122

	registered interest
	date	30/10/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Respiratory System: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will assess the (a) potential effect on the number of antibiotic and (b) potential change in annual prescription and dispensing costs prescriptions of using C-reactive protein testing for patients presenting with respiratory tract infections in primary care.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	14222
	answer	answer is ministerial correction date of answer 09/11/2015 answer text <p>We have no plans to do so.</p><br /><p>The UK Government is committed to tackling antimicrobial resistance. The UK Antimicrobial Resistance Strategy, published in September 2013, proposed strong, cross-government action to manage this problem. The UK strategy recognises the central part diagnostics, like C-reactive protein tests, play in getting the right antibiotic drug to the right patient at the right time. A working group is actively looking at what can be done to improve diagnostic services.</p><p><strong></strong></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/11/2015 16:11:41 answering member 4020 label Biography information for George Freeman
	tabling member	4447 label Biography information for Maggie Throup

454195

	registered interest
	date	23/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Obesity: Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what budget he plans to allocate to each clinical commissioning group in England to support the effective transfer of obesity surgery in April in a manner consistent with NICE's clinical guidelines.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	27869
	answer	answer is ministerial correction date of answer 01/03/2016 answer text <p>NHS England is not currently able to provide a figure for individual clinical commissioning groups on 1 April 2016 as the basis for calculating the figures is still being finalised.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/03/2016 11:09:23 answering member 4020 label Biography information for George Freeman
	tabling member	4447 label Biography information for Maggie Throup

454199

	registered interest
	date	23/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Obesity: Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 10 December 2015 to Question 18621, what further assessment he has made of levels of preparedness among clinical commissioning groups (CCGs) for the planned transfer of obesity surgery commissioning responsibilities to CCGs in April 2016.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	27844
	answer	answer is ministerial correction date of answer 01/03/2016 answer text <p>NHS England is supporting the transfer of commissioning responsibilities to ensure that clinical commissioning groups are fully prepared to assume the role working through collaborative commissioning forums.</p><p> </p><p>NHS England have provided a commissioning information pack including a stocktake of local services, care pathways, waiting times and a quality overview for each local area. National clinical experts are currently finalising commissioning and clinical guidance on standards for the adult obesity surgery pathway.</p><p> </p><p>The draft service specification reflects best practice and describes the standard providers will need to meet for the surgical service.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/03/2016 11:10:58 answering member 4020 label Biography information for George Freeman
	tabling member	4447 label Biography information for Maggie Throup

454221

	registered interest
	date	23/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Obesity: Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what support NHS England plans to provide clinical commissioning groups relating to the transfer of obesity surgery commissioning responsibilities from NHS England after that transfer.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	28115
	answer	answer is ministerial correction date of answer 01/03/2016 answer text <p>Although the transfer is effective from April 2016, the handover process will be agreed between specialised commissioning and individual clinical commissioning groups (CCGs), in line with their preparedness.</p><p> </p><p>Specialised commissioning teams will continue to provide advice and support CCGs post-handover in line with the CCG’s need. CCGs already have mechanisms in place to monitor provider performance and quality through the existing quality assurance processes.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/03/2016 11:07:34 answering member 4020 label Biography information for George Freeman
	tabling member	4447 label Biography information for Maggie Throup

513011

	registered interest
	date	14/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the evidential basis is for NHS England's decision not to fund the pre-exposure drug prophyaxis for HIV for the at-risk population.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	34125
	answer	answer is ministerial correction date of answer 21/04/2016 answer text <p>NHS England has placed its position on the commissioning of pre-exposure prophylaxis (PrEP) under review. This review of the commissioning process will be undertaken by the Specialised Services Committee of NHS England in late May 2016. Depending on the outcome of that decision, a further decision taking account of the clinical evidence for PrEP, the evidence and demand for other new treatments not currently commissioned and NHS England's available funding and priorities is currently planned for June 2016.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/04/2016 14:19:15 answering member 3918 label Biography information for Jane Ellison
	tabling member	4447 label Biography information for Maggie Throup

513019

	registered interest
	date	14/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which areas have been chosen as test sites for the pre-exposure drug prophyaxis (PrEP); what selection criteria have been used to identify those test sites; and what measures his Department plans to use to assess the effectiveness of PrEP in the test sites over the next two years.
	tabling member constituency	Erewash
	tabling member printed	Maggie Throup
	uin	34127
	answer	answer is ministerial correction date of answer 22/04/2016 answer text <p>The planning of the process to select test sites, including timing and criteria for selection, will continue alongside NHS England’s review of its position on the commissioning of pre-exposure prophyaxis (PrEP).</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/04/2016 13:06:13 answering member 3918 label Biography information for Jane Ellison
	tabling member	4447 label Biography information for Maggie Throup